論文

査読有り 筆頭著者 本文へのリンクあり
2021年4月1日

Assessment of mixed plasmodium falciparum sera5 infection in endemic burkitt lymphoma: A case-control study in Malawi

Cancers
  • Nobuko Arisue
  • George Chagaluka
  • Nirianne Marie Q. Palacpac
  • W. Thomas Johnston
  • Nora Mutalima
  • Sally Peprah
  • Kishor Bhatia
  • Eric Borgstein
  • George N. Liomba
  • Steve Kamiza
  • Nyengo Mkandawire
  • Collins Mitambo
  • James J. Goedert
  • Elizabeth M. Molyneux
  • Robert Newton
  • Toshihiro Horii
  • Sam M. Mbulaiteye
  • 全て表示

13
7
記述言語
掲載種別
研究論文(学術雑誌)
DOI
10.3390/cancers13071692

Background: Endemic Burkitt lymphoma (eBL) is the most common childhood cancer in Africa and is linked to Plasmodium falciparum (Pf) malaria infection, one of the most common and deadly childhood infections in Africa; however, the role of Pf genetic diversity is unclear. A potential role of Pf genetic diversity in eBL has been suggested by a correlation of age-specific patterns of eBL with the complexity of Pf infection in Ghana, Uganda, and Tanzania, as well as a finding of significantly higher Pf genetic diversity, based on a sensitive molecular barcode assay, in eBL cases than matched controls in Malawi. We examined this hypothesis by measuring diversity in Pf-serine repeat antigen-5 (Pfsera5), an antigenic target of blood-stage immunity to malaria, among 200 eBL cases and 140 controls, all Pf polymerase chain reaction (PCR)-positive, in Malawi. Methods: We performed Pfsera5 PCR and sequencing (~3.3 kb over exons II–IV) to determine single or mixed PfSERA5 infection status. The patterns of Pfsera5 PCR positivity, mixed infection, sequence variants, and haplotypes among eBL cases, controls, and combined/pooled were analyzed using frequency tables. The association of mixed Pfsera5 infection with eBL was evaluated using logistic regression, controlling for age, sex, and previously measured Pf genetic diversity. Results: Pfsera5 PCR was positive in 108 eBL cases and 70 controls. Mixed PfSERA5 infection was detected in 41.7% of eBL cases versus 24.3% of controls; the odds ratio (OR) was 2.18, and the 95% confidence interval (CI) was 1.12–4.26, which remained significant in adjusted results (adjusted odds ratio [aOR] of 2.40, 95% CI of 1.11–5.17). A total of 29 nucleotide variations and 96 haplotypes were identified, but these were unrelated to eBL. Conclusions: Our results increase the evidence supporting the hypothesis that infection with mixed Pf infection is increased with eBL and suggest that measuring Pf genetic diversity may provide new insights into the role of Pf infection in eBL.

リンク情報
DOI
https://doi.org/10.3390/cancers13071692
Scopus
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103485178&origin=inward 本文へのリンクあり
Scopus Citedby
https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85103485178&origin=inward
ID情報
  • DOI : 10.3390/cancers13071692
  • eISSN : 2072-6694
  • SCOPUS ID : 85103485178

エクスポート
BibTeX RIS